Recent news on Follitropin Alfa

Meeting Highlights From The Committee For Medicinal Products For ...  -  Apr 27, 2007
Medical News Today (press release),Pergoveris (follitropin alfa and lutropin alfa), from Serono Europe Ltd, intended for the stimulation of follicular development in women with severe

Committee for Medicinal Products for Human Use Summary of Positive ...  -  Apr 27, 2007
PharmaLive.com (press release),The active substances of Pergoveris are follitropin alfa (G03GA05) and lutropin alfa (G03GA07), two gonadotrophins produced by genetically engineered

Serono and Syntonix to Pursue the Development of a Long-Acting ...  Sep 17, 2006
Serono is the world leader in the treatment of infertility and currently markets GONAL-f(R) (follitropin alfa), a highly consistent recombinant human follicle ... -Black Enterprise

Serono and Syntonix to Pursue the Development of a Long-Acting ...  Sep 17, 2006
Serono is the world leader in the treatment of infertility and currently markets GONAL-f® (follitropin alfa), a highly consistent recombinant human follicle ... -Yahoo! News

Serono Announces Results From Pivotal Phase III Clinical Trial of ...  Aug 17, 2006
The Company has seven recombinant products, Rebif(R) (interferon beta-1a), Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa), Ovidrel ... -PR Newswire

Get the latest news direct to your desktop  Aug 18, 2006
The Company has seven recombinant products, Rebif® (interferon beta-1a), Gonal-F® (follitropin alfa for injection), Luveris® (lutropin alfa), Ovidrel ... -PipelineReview.com



Phase III Trial Of Oral Cladribine, A Novel Investigational ...  May 5, 2006
The Company has seven biotechnology products in the US, Rebif(R) (interferon beta-1a), Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa ... - Medical News Today



Flat sales in Q4 for Serono; no word on buyer  Feb 6, 2006
The product assumed even more importance for Serono Gonal F (follitropin alfa) declined 12% to $134 million on pricing pressure from arch-rival Organon. ... - Pharma Times (subscription)

Serono to market fertility treatment in Japan  Jan 25, 2006
The Japanese Ministry of Health has approved Gonal-f 75 IU and Gonal-f 150 IU (follitropin alfa recombinant) for co-administration with Profasi 5000 IU ... - Pharmaceutical Business Review

Serono's Gonal-f Approved in Japan for the Treatment of Male ...  Jan 24, 2006
...that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f® 75 IU and Gonal-f® 150 IU (follitropin alfa recombinant) subcutaneous ... - DG News

Serono's Gonal-f Approved in Japan for the Treatment of Male ...  Jan 24, 2006
...that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Gonal-f(R) 75 IU and Gonal-f(R) 150 IU (follitropin alfa recombinant) subcutaneous ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional